SYLVIA ORTEGA: Open Payments
NPI 1215124946 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 56 payments from 13 companies in 2025. Trend: 2023 $604 · 2024 $566 · 2025 $937
Food & beverage: $872Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $237 |
| Janssen Biotech, Inc. | 10 | $210 |
| Galderma Laboratories, L.P. | 12 | $150 |
| LEO Pharma Inc. | 4 | $84 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Organon LLC | 3 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Lilly USA, LLC | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: SKYRIZI, TREMFYA, NEMLUVIO, ADBRY, Zoryve, VTAMA, ILUMYA, TALTZ.
Industry payments across CA — which companies pay providers there.
